Hjem
Christer Frode Aass bilde

Christer Frode Aas

  • E-postChrister.Aas@uib.no
  • Besøksadresse
    Haakon Sheteligs plass 7
  • Postadresse
    Postboks 7808
    5007 BERGEN
Vitenskapelig artikkel
  • Vis forfatter(e) 2021. Substance use and symptoms of mentalhealth disorders: a prospective cohort of patients with severe substance use disorders in Norway. Substance Abuse Treatment, Prevention, and Policy. 10 sider.
  • Vis forfatter(e) 2020. Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017. Substance Abuse Treatment, Prevention, and Policy.
  • Vis forfatter(e) 2020. Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013-2017): a prospective cohort study. BMC Health Services Research. 10 sider.
  • Vis forfatter(e) 2020. Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017. BMJ Open. 10 sider.
  • Vis forfatter(e) 2020. On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: A prospective cohort study from 2013 to 2017. BMJ Open. 1-9.
  • Vis forfatter(e) 2020. Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020. Substance Abuse Treatment, Prevention, and Policy. 11 sider.
  • Vis forfatter(e) 2020. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway. Substance Abuse Treatment, Prevention, and Policy. 1-12.
  • Vis forfatter(e) 2020. Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; A prospective cohort study in Norway from 2013 to 2017. BMC Health Services Research. 1-12.
  • Vis forfatter(e) 2020. Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; A national prospective cohort study in Norway from 2015 to 2017. BMC Psychiatry. 1-12.
  • Vis forfatter(e) 2019. Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV). BMC Infectious Diseases. 1-9.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) 2019. Integrated care of severe infectious diseases to people with substance use disorders; a systematic review. BMC Infectious Diseases. 1-15.

Se fullstendig oversikt over publikasjoner i CRIStin.